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Abstract
Background: Dental pulp stem cells (DPSCs) are increasingly being recognized as a viable cell source for
regenerative medicine. Although significant variations in their ex vivo expansion are well-established, DPSC
proliferative heterogeneity remains poorly understood, despite such characteristics influencing their regenerative
and therapeutic potential. This study assessed clonal human DPSC regenerative potential and the impact of cellular
senescence on these responses, to better understand DPSC functional behaviour.
Results: All DPSCs were negative for hTERT. Whilst one DPSC population reached >80 PDs before senescence,
other populations only achieved <40 PDs, correlating with DPSCs with high proliferative capacities possessing
longer telomeres (18.9 kb) than less proliferative populations (5–13 kb). High proliferative capacity DPSCs exhibited
prolonged stem cell marker expression, but lacked CD271. Early-onset senescence, stem cell marker loss and
positive CD271 expression in DPSCs with low proliferative capacities were associated with impaired osteogenic and
chondrogenic differentiation, favouring adipogenesis. DPSCs with high proliferative capacities only demonstrated
impaired differentiation following prolonged expansion (>60 PDs).
Conclusions: This study has identified that proliferative and regenerative heterogeneity is related to contrasting
telomere lengths and CD271 expression between DPSC populations. These characteristics may ultimately be used
to selectively screen and isolate high proliferative capacity/multi-potent DPSCs for regenerative medicine
exploitation.
Keywords: Dental pulp, Stem cells, Cumulative population doublings, Telomeres, Cellular senescence,
Differentiation, Multi-potency, CD271
Background
Dental pulp stem cells (DPSCs) are increasingly be-
coming recognized as a viable cell source for the de-
velopment of effective cell-based therapies. This is
due to their accessibility, multi-lineage differentiation
capabilities towards osteogenic, chondrogenic, myo-
genic and neurogenic lineages; and similar regenera-
tive properties to bone marrow-derived cells [1–4].
DPSCs exhibit a fibroblast-like morphology, plastic
adherence, express mesenchymal stem cell (MSC)
markers (CD73, CD90 and CD105); and thus satisfy
the minimal criteria for MSCs [1, 3, 5, 6]. However,
similar to bone marrow stem cells, DPSCs isolated
from pulpal tissues are recognised to represent a het-
erogeneous population, with individual isolated clones
demonstrating differences in proliferative rates and
their abilities to differentiate down particular lineages
[1, 5, 7]. Indeed, despite heterogeneous DPSC popula-
tion expansion being capable of achieving >120 cu-
mulative population doublings (PDs) in vitro, only
20% of purified DPSCs are capable of proliferating be-
yond >20 PDs. Of these, only two-thirds were able to
generate abundant ectopic dentine in vivo, implying
that subset DPSC populations differ in their regenera-
tive potential [5, 7]. In vitro, heterogeneous DPSCs
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can differentiate into osteoblasts, chondrocytes, adipo-
cytes, neurocytes and myocytes, but it has been re-
ported that there are occasions when DPSCs fail to
differentiate into adipocytes, chondrocytes and myo-
blasts; suggested to be a consequence of the potential
stem cell niches within dental pulp tissue [1].
Adult stem cells are proposed to exist in a hierarchical
arrangement. Pivotal to this model is the mother stem
cell, which divides slowly and asymmetrically to yield a
replacement mother cell and rapidly dividing transit
amplifying (TA) cells [8]. It has been proposed that as
TA cells continue to divide, their proliferative capacity is
reduced and they become more lineage-restricted. In
contrast, newly formed TA cells possess a greater prolif-
erative and multi-differentiation capacity. The presence
of TA cells has been suggested to rise within the post-
natal dental pulp, which are the first to differentiate into
new odontoblast-like cells following cavity-induced in-
jury [9]. Whilst this would indicate a strong role for TA
cells in tissue repair and regeneration, the nature, origins
or the relationship of DPSC populations with contrasting
proliferative capacities to this hierarchical arrangement,
have yet to be elucidated.
Another important requirement for the tissue engin-
eering exploitation of stem cells is the considerable in
vitro cell expansion required before sufficient cell num-
bers are obtained for therapeutic use. However, a signifi-
cant limitation of stem cell therapy is that extensive in
vitro cell expansion eventually leads to proliferative de-
cline and cellular senescence, accompanied by altered
cellular behaviour and impaired regenerative potential
[10]. This feature has been particularly reported for the
in vitro expansion of MSCs from human bone marrow,
where no more than 4–7 PDs is recommended in prepa-
rations for therapeutic use [11]. For most cell types, in
vitro expansion and subsequent cellular senescence is a
consequence of replicative (telomere-dependent) senes-
cence, characterised by progressive telomere shortening
and the loss of telomeric TTAGGG repeats, due to re-
peated cell divisions [12]. Cellular senescence may also
occur through DNA damage by p53, ionizing radiation
or oxidative stress (premature or telomere-independent
senescence). Either mechanism is associated with the ac-
tivation of various signalling pathways, including those
involving the tumour suppressor genes, p53 and retino-
blastoma protein (pRb), via the cyclin-dependant kinase
inhibitors, p21waf1 and p16INK4a, respectively [12]. How-
ever, foetal cells, germ lines, stem cells and many
tumour cells are established to contain the human tel-
omerase catalytic subunit (hTERT); a reverse transcript-
ase capable of the complete replication of telomere ends,
which plays a major role in counteracting erosion, main-
taining telomeric integrity and proliferative lifespan in
these cells [13].
Although significant differences in the ex vivo expan-
sion capabilities of individual DPSC populations has
been recognized for some time, few studies have ad-
dressed the reasons behind these differences and the
subsequent impact of such variations on differentiation
and regenerative potential. Consequently, this study
aimed to examine whether inherent differences in telo-
mere lengths and relative susceptibilities to cellular
senescence between individual DPSC populations, con-
tributed to the significant variations in proliferative and
differentiation capabilities identified for individual
DPSC populations. To achieve this, proliferative life-
spans, stem cell marker expression, multi-potent differ-
entiation capabilities and senescence-related marker
development, were characterized for individual DPSC
populations expanded from individual human teeth de-
rived from young adults with a similar donor age range.
Methods
DPSC isolation, culture and population doubling levels
Human third molar teeth were collected from three young
adult patients (Patients A-C, all female, age range 18–30
years), undergoing orthodontic extractions at the School of
Dentistry, Cardiff University, UK. Teeth were collected
with informed patient consent and ethical approval by the
South East Wales Research Ethics Committee of the Na-
tional Research Ethics Service (NRES), UK. The outer sur-
face of the teeth were sterilised with 70% ethanol. Teeth
were grooved in the mesial, distal and occlusal regions with
a rotary bone saw; and halved. Pulps were removed,
minced on a glass slide; and the cells were released from
the pulpal tissues by digestion with 4 μg/μl collagenase/dis-
pase (1 ml, Roche, Welwyn Garden City, UK), for 45 min
at 37 °C. Pulpal tissues from individual patients were pre-
pared separately. Digests were passed through a 70 μmmesh
cell strainer and the eluents collected to obtain single cell
suspensions. Cells were centrifuged and further re-
suspended in 1 ml culture medium; α-Minimum Essential
Medium (αMEM) containing ribonucleosides, deoxyribo-
nucleosides, 4 mM L-glutamine, 100 U/ml penicillin G so-
dium, 0.1 μg/ml streptomycin sulphate, 0.25 μg/ml
amphotericin; and 20% foetal calf serum (all Invitrogen,
Paisley, UK), in addition to 100 μM L-ascorbate 2-
phosphate (Sigma-Aldrich, Poole, UK).
The present study utilised a fibronectin adhesion assay
to preferentially select and isolate immature DPSCs,
based on their expression of high β1-integrin levels on
stem cell surfaces [14]. This fibronectin adhesion isola-
tion method has previously been used successfully for
the isolation of tissue-specific, immature stem / progeni-
tor cells from dental pulp [15, 16], oral mucosa [17], car-
tilage [18]; and bone marrow [16]. Briefly, viable cell
counts were calculated and cells seeded onto
fibronectin-coated, 6-well plates, at 4000 cells/cm2.
Alraies et al. BMC Cell Biology  (2017) 18:12 Page 2 of 14
Plates were subsequently maintained at 37 °C / 5% CO2
for 20 min, in accordance with our previously published
protocol [15, 16]. Following adhesion, the culture
medium and non-adherent cells were removed and re-
placed with 2 ml αMEM medium. Medium was replen-
ished every 2 days.
Colonies (>32 cells) were allowed to form over 12 days
in culture, with individual colonies isolated within clon-
ing rings using 100 μl pre-warmed, accutase (PAA,
Velizy-Villacoublay, France); and seeded into 1 well of a
96-well plate. Isolated colonies were subsequently ex-
panded until the numbers were sufficient for seeding
into T-75 flasks. Of the DPSC colonies established from
Patients A-C, six populations (A1, A2 and A3; B1; C2
and C3) were expanded, with PDs for each DPSC popu-
lation calculated from cell counts throughout their pro-
liferative lifespans in culture until reaching senescence,
as previously described [19]. DPSC senescence was iden-
tified when PDs were reduced to <0.5 PDs / week and
later confirmed by the increased presence of other
senescence-related markers, as described below.
Telomere length determination
DPSCs at various PDs throughout their proliferative life-
spans (A1, B1 and C2 at 8 PDs, A2 at 12 PDs, A3 at 9
PDs and 55 PDs, C3 at 16 PDs), were seeded in T-75
flasks at 5000 cells / cm2 and grown to confluence. Gen-
omic DNA was isolated from each DPSC population
using QIAmp® DNA Mini Kits (Qiagen, Crawley, UK),
according to manufacturer’s instructions; and DNA
yields quantified at 260 nm (NanoVue, GE Healthcare,
Amersham, UK). Telomere length assessments were per-
formed using the TeloTAGGG Telomere Restriction
Fragment Length (TRF) Assay Kit (Roche), according to
manufacturer’s instructions. Briefly, each DNA sample
(1 μg) was digested with HinF1 / Rsa1 (both 40 U / μl,
in Kit), at 37 °C for 2 h. DPSC samples, a digoxigenin
(DIG)-labelled, Molecular Weight Marker and a positive
DIG-labelled, Control DNA sample (both in Kit), were
separated (20 mV, overnight) on 0.8% by agarose gels
(Agarose MP, Geneflow, Lichfield, UK); in 1x Tris-
acetate-EDTA buffer containing 0.2 μg/ml ethidium
bromide (Sigma-Aldrich). Gels were subsequently
treated with 0.25 M hydrochloric acid solution (Thermo
Fisher Scientific) and rinsed (x2) with water, before treat-
ment (x2) with Denaturation Solution (0.5 M sodium
hydroxide, 1.5 M sodium chloride solution), rinsing (x2);
and treatment with Neutralisation Solution (0.5 M Tris-
HCl buffer, pH 7.5, containing 3 M sodium chloride).
Separated products were transferred onto positively
charged nylon membranes (Roche) by Southern blotting;
using 20× standard sodium citrate (SSC) buffer (3 M so-
dium chloride / 0.3 M sodium citrate solution, pH 7.0).
Nylon membranes were fixed by UV-crosslinking for
2 × 10 s (Stratalinker, Agilent Technologies, Stockport,
UK) and washed with SSC (x2), prior to hybridisation
with DIG Easy Hyb (in Kit), for 1 h at 42 °C. This was
replaced with Hybridisation Solution mixed with Telo-
mere Probe (2 μl, in Kit); and incubated at 42 °C for 3 h.
Membranes were consecutively washed (x2) with 25 ml
Stringent Wash Buffers, before incubations in Blocking
Solution, Anti-DIG-AP Working Solution, Washing Buf-
fer (x2); and Detection Buffer, respectively (all in Kit). Fi-
nally, membranes were incubated for 5 min in
Chemiluminescent Substrate Solution (in Kit), before be-
ing exposed (30 s) to X-ray film (Hyperfilm®, GE Health-
care) and developed.
Average DPSC telomere lengths at each PD were cal-
culated from the Southern blot images, using ImageJ®
Software (http://rsb.info.nih.gov/ij/), to quantify the den-
sitometic intensity profile of the entire length of the sep-
arated products within each particular lane. In line with
TRF Assay Kit instructions, each lane was overlaid along
its entire length with a grid consisting of 30 equal
squares, where telomere-specific signal was detectable.
The background intensity of each lane was calculated by
selecting squares within each lane containing no
telomere-specific signal and by subtracting these aver-
aged values from the squares containing telomeric sig-
nal. For each square containing detectable telomeric
signal, the total signal density within each square (ODi)
and the corresponding molecular weight at the mid-
point of each square (Li) (based on the DIG-labelled,
Molecular Weight Marker bands, kb), were calculated.
Average telomere lengths were subsequently calculated,
using the following formula, where ODi is the chemilu-
minescent signal and Li is the length of the telomeres at
position i:-
Σ ODið Þ
Σ ODi= Lið Þ
Stem cell and senescence-related marker expression
DPSCs were examined by RT-PCR for the expression of
purported stem / progenitor cell markers (CD73, CD90,
CD105, CD271) and the absence of the hematopoietic stem
cell marker (CD45); at various PDs throughout their prolif-
erative lifespans (1–10 PDs, 11–23 PDs, 24–60 PDs and
where applicable, >60 PDs). In addition, DPSCs at early
PDs were assessed for the expression of hTERT, whilst ex-
pression of the senescence-associated marker genes, p53,
p21waf1 and p16INK4a, were analysed for all DPSCs at PDs
throughout their proliferative lifespans. DPSCs were cul-
tured in 6-well plates until ~90% confluence. Total RNA
was isolated for DPSCs using an RNeasy Mini Kit (Qiagen),
according to the manufacturer’s instructions. RNA was
quantified by measurement of 260:280 nm ratio
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(NanoVue). cDNA was synthesised from 1 μg total RNA,
using 5x Moloney murine leukaemia virus (M-MLV) buffer,
0.5 μg Random Primers, 0.625 μl RNasin, 1.25 μl dNTPs
(10 mM) and 1 μl M-MLV reverse transcriptase, reconsti-
tuted to 25 μl with DNase-free water (all Promega, South-
ampton, UK, total volume 15 μl). All reactions were
performed on a G-storm™ GS1 Thermal Cycler (Genetic
Research Instrumentation, Braintree, UK), at 37 °C for 1 h,
followed by 95 °C for 5 min.
PCR reactions were established including cDNA (1 μl),
5x Green GoTaq™ Flexi Buffer (5 μl), 25 mM Magnesium
Chloride Solution (1 μl), 10 mM PCR Nucleotide Mix
(0.5 μl), 5 U / μl GoTaq™ DNA Polymerase (0.25 μl, all
Promega), 0.04 μg/μl forward primer and 0.04 μg/μl re-
verse primer (both 1.25 μl). PCR were performed using
the primer sequences and cycling conditions described
in Table 1, with β-actin serving as the reference house-
keeping gene in all cases. Primer replacement with
DNase-free water served as the negative controls. All re-
action volumes were made up to 25 μl with DNase-free
water. Reactions were run on a G-storm™ GS1 Thermal
Cycler, with an initial denaturing step of 95 °C (5 min),
followed by 35–40 cycles at 95 °C (1 min), 1 cycle at 55–
62 °C (1 min), 1 cycle at 72 °C (1 min); and 1 cycle at
72 °C (5 min). PCR products and a 100 bp DNA ladder
(Promega) were separated on 2% agarose gels (125 mV,
45 min), in 1x Tris-acetate-EDTA buffer (above). Gel
images were captured under UV light and analysed using
a Gel Doc 3000 Scanner and Image Analysis Software
(Bio-Rad, Hemel Hempstead, UK).
DPSC differentiation capabilities
Based on the distinct proliferative differences identified
above between A3 and the other DPSC populations
assessed, further studies compared the respective osteo-
genic chondrogenic and adipogenic differentiation cap-
abilities of A3 (at 30 PDs, 62 PDs, and 75 PDs), versus
low proliferative capacity DPSC populations, A1 (17
PDs) and B1 (25 PDs). Differentiation was assessed using
commercially available media (OsteoDiff, ChondroDiff
and AdipoDiff, Miltenyi Biotec, Bisley, UK), according to
manufacturer’s protocols and following supplementation
with antibiotics, as above.
For the analysis of osteogenic capabilities, DPSCs were
seeded at 4.5x103 cells / cm2 in 6- or 12-well plates; and
maintained in OsteoDiff medium at 37 °C / 5% CO2 for
18 days. Medium was replenished every 3 days. At day
18, cells in 6-well plates were used for the RT-PCR
Table 1 Details of the primer sequences and cycling conditions used for RT-PCR
Gene marker Primer sequence Annealing temp. (°C) Cycles NCBI reference sequence
CD73 F:5′GTCGCGAACTTGCGCCTGGCCGCCAAG-3′
R: 5′-TGCAGCGGCTGGCGTTGACGCACTTGC-3′
65 35 NM_001204813.1
CD90 F:5′- ATGAACCTGGCCATCAGCATCG-3′
R:5′- CACGAGGTGTTCTGAGCCAGCA-3′
55 35 NM_006288.3
CD105 F:5′-GAAACAGTCCATTGTGACCTTCAG-3′
R: 5′-GATGGCAGCTCTGTGGTGTTGACC-3′
65 35 NM_001114753.2
CD271 F:5′- CTGCAAGCAGAACAAGCAAG-3′
R:5′- GGCCTCATGGGTAAAGGAGT-3′
55 35 NM_002507.3
CD45 F:5′-GTGACCCCTTACCTACTCACACCACTG-3′
R:5′-TAAGGTAGGCATCTGAGGTGTTCGCTG-3′
65 35 NM_002838.4
hTERT F:5′- CGGAAGAGTGTCTGGAGCAA-3′
R:5′- GGATGAAGCGGAGTCTGGA-3′
55 40 NM_198253.2
p53 F:5′- AGACCGGCGCACAGAGGAAG-3′
R:5′- CTTTTTGGACTTCAGGTGGC-3′
55 35 NM_001126118.1
p21waf1 F:5′- GGATGTCCGTCAGAACCCAT-3′
R:5′- CCCTCCAGTGGTGTCTCGGTG-3′
60 35 NM_001291549.1
p16INK4A F:5′- CTTCCTGGACACGCTGGT-3′
R:5′- GCATGGTTACTGCCTCTGGT-3′
55 35 NM_001195132.1
OCN F:5′-GCAGGTGCGAAGCCCAGCGGTGCAGAG-3′
R: 5′-GGGCTGGGAGGTCAGGGCAAGGGCAAG-3′
62 35 NM_199173.4
OPN F:5′- ATCACCTGTGCCATACCA-3′
R:5′- CATCTTCATCATCCATATCATCCA-3′
55 35 NM_001251830.1
PPARγ F:5′-GCCATCAGGTTTGGGCGGATGCCACAG-3′
R: 5′-CCTGCACAGCCTCCACGGAGCGAAACT-3′
62 35 NM_138711.3
LPL F:5′-GCTGGCATTGCAGGAAGTCTGACCAATAA-3′
R:5′-GGCCACGGTGCCATACAGAGAAATCTCAA-3′
55 35 NM_000237.2
β-actin F:5′-AGGGCAGTGATCTCCTTCTGCATCCT-3′
R:5′- CCACACTGTGCCCATCTACGAGGGGT-3′
65 35 NM_001101.3
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analysis of Runx2, osteocalcin (OCN) and osteopontin
(OPN) expression (Table 1), whilst the 12-well plates
were washed (x2) with phosphate buffered saline (PBS)
and fixed with 4% paraformaldehyde (Santa Cruz, Dallas,
USA) for 10 min and washed with PBS (x2). Osteogenic
cultures were assessed for mineral nodule deposition de-
tection by staining with 2% alizarin red solution, pH 4.2
(500 μl / well, Sigma-Aldrich), for 3 min. Images repre-
senting the extent of alizarin red staining were captured
by light microscopy (Eclipse TS100, Nikon UK, Kingston
upon Thames, UK), using a digital camera (Canon
PC1234, Uxbridge, UK).
Chondrogenic capacity was analysed using single cell
suspensions containing 2.5 × 105 DPSCs in 1 ml medium,
which were centrifuged to produce cell pellets. Medium
was replaced with 1 ml of ChondroDiff medium, prior to
re-centrifugation. Pellets were maintained in ChondroDiff
medium at 37 °C/5% CO2 for 24 days. Medium was replen-
ished every 3 days. At day 24, pellets were washed (x1)
with PBS, prior to fixation overnight in 3.7% neutral buff-
ered formalin. Each pellet underwent automated histo-
logical processing (Leica ASP300 S, Leica Microsystem,
Milton Keynes, UK), through a graded alcohol series and
paraffin wax embedding. Sections (5 μm) were cut using a
sliding microtome (Leica SM2400, Leica Microsystems),
collected onto poly-L-lysine coated slides (SuperFrost,
Thermo Fisher Scientific); and dried. Sections were depar-
affinised and rehydrate with xylene (10 min), industrial
methylated spirits (5 min) and water (5 min). Pellet sec-
tions were treated with fast green FCF solution (1:5000,
Sigma-Aldrich) for 5 min and washed in 1% acetic acid
(Thermo Fisher Scientific). Sections were assessed for pro-
teoglycan content by 0.1% Safranin O staining (Sigma-Al-
drich) for 10 min; and washed in 95% ethanol-xylene
mixture (1:1). Images representing the extent of Safranin O
staining were captured, as above.
For the analysis of adipogenic capabilities, DPSCs were
seeded at 7.5 × 103 cells / cm2 in 6- or 12-well plates; and
maintained in AdipoDiff medium at 37 °C/5% CO2 for
21 days. Medium was replenished every 3 days. At day 21,
cells in 6-well plates were used for the RT-PCR analysis of
adipogenic marker, lipoprotein lipase (LPL) and PPARγ
expression (Table 1), whilst the 12-well plates were
washed (x2) with PBS and assessed for intracellular lipid-
rich vacuole accumulation by Oil Red O staining (500 μl/
well, Sigma-Aldrich; 3.5 g/l in isopropanol, mixed 3:2 with
double-distilled water), for 10 min. Following excess stain
removal with double-distilled water and 60% isopropanol,
images representing the extent of Oil Red O staining were
captured, as above.
DPSC morphology and size assessment
Digital images were captured, as above, to assess changes in
cellular size and morphology throughout each DPSC’s
proliferative lifespan. Random cells (20 cells / image, 3 im-
ages / PD) were outlined along their peripheral borders and
cellular surface areas calculated, using ImageJ® Software.
Surface areas were expressed as an average ± standard error
of the mean (SE) for each DPSC population and PD.
Senescence-associated β-galactosidase staining
DPSCs at defined PDs throughout their proliferative life-
spans were seeded into 6-well plates at 5000 cells/cm2
and maintained at 37 °C / 5% CO2 for 24 h. A Senes-
cence Cell Histochemical Kit (Sigma-Aldrich) was used
to detect senescence-associated β-galactosidase activity
in these cells, according to manufacturer’s instructions.
Culture medium was aspirated and the cells washed (x2)
with PBS (in Kit). DPSCs were treated with Fixation Buf-
fer (1.5 ml / well, in Kit) for 7 min and washed (x3) with
PBS (1 ml / well). Cells were further treated with Stain-
ing Solution (1 ml / well, in Kit) and incubated at 37 °C
/ 5% CO2, overnight. Digital images representing the
extent of senescence-associated β-galactosidase staining
were captured by light microscopy, as above. Random
cells (100 cells in total) were counted and the percentage
number of positive β-galactosidase stained cells
calculated.
Statistical analysis
Statistical analysis on the differences in cellular surface
area (average ± SE) between DPSC populations through-
out their proliferative lifespans, was determined by one-
way ANOVA with post-test Tukey multiple comparison
analysis, using GraphPad InStat 3 (GraphPad Software,
La Jolla, USA). Statistical significance were considered at
p < 0.05.
Results
DPSC isolation, expansion and population doubling levels
Following the isolation of immature DPSC populations
using the fibronectin adherence selection methodology
[15, 16], DPSCs were allowed to form colonies of >32
cells over a 12 day period. Of the DPSC colonies estab-
lished, a selection of six populations (A1, A2 and A3; B1;
C2 and C3), were subsequently expanded in vitro
through to senescence, confirmed when cumulative PDs
fell to <0.5 PDs/week. The cumulative PDs for each
DPSC population are presented in Fig. 1a. Marked varia-
tions in proliferative capacity were evident between indi-
vidual DPSC populations, with each demonstrating
differences in PDs, irrespective of whether DPSCs were
derived from the same or different patients. This was
particularly apparent with A3, which demonstrated the
highest PD levels (>80 PDs) over 280 days in culture,
whilst other DPSC populations from the same patient
(A1 and A2) and different patients (B1, C2 and C3) only
achieved between 20 and 35 PDs over 35–85 days in
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Fig. 1 (See legend on next page.)
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culture. In support of the contrasting PDs capabilities
between these DPSC populations, telomere length ana-
lysis demonstrated much longer average telomere
lengths with high proliferative capacity, A3 (18.9 kb),
compared with DPSCs with low proliferative capacities
at comparable PDs, A1 (5.9 kb), A2 (9.6 kb), B1 (5.6 kb),
C2 (7.2 kb) and C3 (12.8 kb) (Fig. 1b and c). The
consistency of analysis between separate Southern blots
was confirmed by the average telomere lengths calcu-
lated for each positive Control DNA sample on each blot
(i.e. 10.6 ± 0.73 kb, 11.4 ± 0.71 kb and 11.1 ± 0.60 kb, for
the CTRL lanes from left-right in Fig. 1b, respectively).
Stem cell and senescence-related marker expression
Each DPSC population was further investigated to com-
pare stem/progenitor cell marker expression at early
PDs (Fig. 2). All DPSCs demonstrated the expression of
the MSC markers (CD73, CD90 and CD105) and the ab-
sence of the hematopoietic marker, CD45 [3]. Low pro-
liferative capacity DPSCs (A1, A2, B1, C2 and C3) were
also positive for the expression of nerve growth factor
receptor p75 (CD271). All DPSCs analysed also demon-
strated the expression of the senescence-associated
marker genes, p21waf1 and p16INK4a, at early PDs; al-
though p16INK4a expression appeared to be much less
for the high proliferative capacity, A3, than with the low
proliferative capacity DPSCs (A1, A2, B1, C2 and C3).
Similarly, the other senescence-associated marker inves-
tigated, p53, was only expressed in the low proliferative
capacity DPSCs (A1, A2, B1, C2 and C3); being un-
detectable in high proliferative capacity, A3. All DPSCs
analysed were negative for hTERT expression.
DPSC differentiation capabilities
Based on the contrasting PDs identified between A3 and
the other DPSCs assessed, further studies evaluated
whether these populations also possessed contrasting
differentiation capabilities. Tri-lineage (osteogenic, chon-
drogenic and adipogenic) differentiation was compared
between high proliferative capacity, A3 (30 PDs), versus
two low proliferative capacity DPSCs (A1 at 11 PDs, B1
at 15 PDs). Only high proliferative capacity, A3,
demonstrated multi-potency. Osteogenic differentiation
was demonstrated by positive staining with alizarin red
and the up-regulation of OCN and OPN after 18 days in
osteogenic medium (Fig. 3a). Chondrogenic differenti-
ation was evident by positive Safranin O staining for
high proteoglycan content, following 24 days in chon-
drogenic medium (Fig. 3b). However, mRNA extraction
from cartilage pellets was difficult and thus, prevented
gene expression analysis. A3 was also able to undergo
adipogenic differentiation, evident by the presence of Oil
Red O-positive, lipid vacuoles and the up-regulation of
the late adipogenic marker, LPL, expression after 21 days
(See figure on previous page.)
Fig. 1 Characterisation of DPSC populations derived from human dental pulp tissues. a Cumulative population doublings (PDs) were recorded for
six DPSC populations during extended culture until senescence was reached, when PDs reached <0.5 PDs / week. DPSCs A1, A2 and A3 were
derived from patient A, while B1, C2 and C3 were derived from patients B and C, respectively. Population A3 demonstrated high proliferative
capacity, achieving >80 PDs over 280 days in culture, whilst the other DPSC populations only achieved 20–35 PDs over 35–85 days in culture. b
Telomere length analysis for the six DPSC populations at cited PDs, by Southern blotting. Average telomere lengths were calculated using
ImageJ® Software. Much longer telomeres were identified with high proliferative capacity, A3 (18.9 kb), compared with low proliferative capacity
populations, A1 (5.9 kb), A2 (9.6 kb), B1 (5.6 kb), C2 (7.2 kb) and C3 (12.8 kb). A3 (18.9 kb, 9 PDs) only exhibited equivalent telomere lengths to
low proliferative capacity DPSCs, at much later PDs towards the end of its proliferative lifespan (6.4 kb, 55 PDs). CTRL lanes represent the separate
DIG-labelled, Control DNA sample. Average telomere lengths values obtained for each CTRL lane from left-right, were 10.6 ± 0.73 kb, 11.4 ±
0.71 kb and 11.1 ± 0.60 kb, respectively. Separated DIG-labelled telomere length standards are also included. c Correlation between cumulative
PDs versus original telomere lengths for all DPSCs analysed
Fig. 2 Gene expression analysis of DPSC populations by RT-PCR, at
early PDs. All DPSCs showed positive expression for the MSC markers,
CD73, CD90 and CD105; and the absence of the hematopoietic marker,
CD45. All DPSCs analysed were also negative for hTERT. Only
low proliferative capacity DPSCs (A1, A2, B1, C2 and C3) were
positive for the expression of CD271 (nerve growth factor
receptor p75, LNGFR) and for all 3 senescence-associated marker
genes analysed, p53, p21waf1 and p16INK4a. Replacement of cDNA
with H2O served as negative controls, with β-actin serving as the
reference housekeeping gene
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in adipogenic medium (Fig. 3c). In contrast, low prolifer-
ative capacity DPSCs, A1 and B1, were uni-potent for
osteogenic differentiation only and to a lesser extent
than high proliferative capacity, A3; as confirmed by ali-
zarin red staining and OCN / OPN expression (Fig. 3a).
Of note, all three DPSCs expressed the early osteogenic
and adipogenic markers, Runx2 and PPARγ, irrespective
of differentiation status (Fig. 3a and c).
Prolonged in vitro expansion effects on DPSCs
A decline in cellular proliferative capacity is well-
established to correlate with the onset of cellular senes-
cence; and the increased presence of characteristics asso-
ciated with cellular ageing. At early (7–8 PDs), all DPSCs
were morphologically similar, with the characteristic long,
spindle, bipolar shape; and were negative for senescence-
associated β-galactosidase staining (Fig. 4a). Conversely, at
PDs towards the later stages of their respective prolifera-
tive lifespans (examples shown for A1 at 23 PDs, A3 at 83
PDs and B1 at 34 PDs), higher percentages of cells stained
positive for β-galactosidase and were larger and more
stellate-like in appearance, with prominent stress fibres
(Fig. 4a). This was confirmed by cell surface area measure-
ments (Fig. 4b), which demonstrated significant increases
in the surface areas of DPSCs, A1 and A3, with prolifera-
tive lifespan (for A1, approximately 6-fold between 4 PDs
and 15 PDs, 12-fold between 4 PDs and 22 PDs; for A3,
approximately 6-fold between 3 PDs and 21 PDs; and 12-
fold between 3 PDs and 85 PDs; all p < 0.001). However,
only when high proliferative capacity, A3, had reached
Fig. 3 Osteogenic, chondrogenic and adipogenic differentiation of DPSCs. Tri-lineage differentiation analysis was compared between high
proliferative capacity, A3 (30 PDs) and low proliferative capacity DPSCs, A1 (11 PDs) and B1 (15 PDs). a Osteogenesis was confirmed for each DPSC
population by the detection of alizarin red staining for mineralised calcium nodules. No staining was observed in control DPSC cultures in the
absence of osteogenic medium. RT-PCR analysis of osteogenic markers (right panel) indicated increased osteocalcin (OCN) and osteopontin (OPN)
expression for DPSCs cultured in osteogenic media. Cells maintained in both osteogenic and control media expressed Runx2. b Chondrogenesis
was only particularly evident with high proliferative capacity, A3, which exhibited positive Safranin O staining for high proteoglycan content. No
Safranin O staining was observed with the low proliferative capacity DPSCs, A1 and B1. c Adipogenesis was only particularly evident with high
proliferative capacity, A3, which exhibited positive Oil Red O staining for intracellular lipid-rich vacuole accumulation. No Oil Red O staining was
observed with the low proliferative capacity DPSCs, A1 and B1; or in control cultures in the absence of adipogenic medium. RT-PCR analysis of
adipogenic markers (right panel) indicated increased expression of the early adipogenic marker, PPARγ, in all DPSCs maintained in both adipogenic
and control cultures; whilst the late adipogenic marker, lipoprotein lipase (LPL), was only expressed in high proliferative capacity, A3, in adipogenic
media. Scale bars = 100 μm. β-actin served as the reference housekeeping gene
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senescence at 85 PDs did it exhibit similar non-significant,
cell surface area values to senescent low proliferative cap-
acity, A1 populations, at 22 PDs (p > 0.05). B1 also demon-
strated similar trends of increasing cell surface area with
proliferative lifespan, with significant increases in the sur-
face areas with proliferative lifespan (approximately 2.5-
fold between 4 PDs and 18 PDs; and 5-fold between 4
PDs and 35 PDs (both p < 0.001). However, senescent B1
surface areas at 35 PDs did not reach the cell area sizes of
senescent A1 or A3 at 22 PDs and 85 PDs, respectively.
Although the stem/progenitor cell markers, CD73,
CD90 and CD105, were previously shown to be
expressed by DPSCs, A1, A3 and B1, at early PDs, the
expression of these markers was gradually lost during in
vitro expansion (Fig. 4c). CD105 appeared to be lost ini-
tially, based on expression levels in A1 (11 PDs) and A3
Fig. 4 Effects of prolonged in vitro culture expansion on DPSC ageing characteristics. a Digital images representing the extent of senescence-
associated β-galactosidase staining by DPSCs at early PDs (7–8 PDs) and towards the end of their respective proliferative lifespans (A1 at 23 PDs,
A3 at 83 PDs and B1 at 34 PDs). At 7–8 PDs, all DPSCs were morphologically similar, with the characteristic MSC morphology and were negative
for β-galactosidase staining. At PDs towards the later stages of their respective proliferative lifespans, higher percentages of cells stained positive
for β-galactosidase, which were larger, more stellate-like and with prominent stress fibres. Scale bars = 100 μm. b Analysis of cellular surface area
throughout the proliferative lifespan of A1, A3 and B1, using ImageJ® Software (average ± SE, **p < 0.001). Significant increases in each DPSC
population’s surface area were identified with proliferative lifespan. Only when high proliferative capacity, A3, reached senescence (85 PDs) were
surface areas non-significantly different to senescent A1 populations at 22 PDs (p > 0.05). Senescent B1 surface areas at 35 PDs did not reach the
cell area sizes of senescent A1 or A3 at 22 PDs and 85 PDs, respectively. c Gene expression of the MSC markers, CD73, CD90 and CD105, was
gradually lost during in vitro expansion. CD105 was lost initially, based on expression levels in A1 (11 PDs) and A3 (24 PDs), whilst CD90 and
CD73 expression was subsequently lost towards the end of each population’s respective proliferative lifespans. Whilst the premature loss of
CD105 was not as apparent with B1, all three markers were lost towards the end of its proliferative lifespan (24 PDs). NA indicates that no cells
were available for analysis at these PDs. β-actin served as the reference housekeeping gene
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(24 PDs). CD90 and CD73 expression was subsequently
lost from these DPSC populations towards the end of
their respective proliferative lifespans. Whilst the prema-
ture loss of CD105 was not apparent with B1, all three
markers were lost towards the end of its proliferative
lifespan.
Prolonged in vitro expansion effects on DPSC
differentiation
In light of the superior proliferative capacity and multi-
potent differentiation properties of the A3 population at
early PDs, we also determined whether these preferential
differentiation capabilities were diminished with pro-
longed in vitro expansion, in line with those of low prolif-
erative capacity DPSCs, A1 and B1. A3 telomere lengths
decreased from 18.9 kb (9 PD) to 6.4 kb (55 PD) (Fig. 1b).
In line with such decreases in telomere length, the osteo-
genic potential of A3 was greatly reduced following cul-
ture expansion from 30 PDs to 62 PDs and 75 PDs,
apparent by a reduction in alizarin red staining and the
loss of osteogenic marker, Runx2, OCN and OPN, expres-
sion (Fig. 5a). However, subsequent analyses indicated that
the clear loss of A3 osteogenic differentiation potential at
75 PDs, was concomitant with the increased presence of
enlarged intracellular lipid vesicles (Oil Red O staining)
and the increased expression of early and late adipogenic
markers, PPARγ and LPL (Fig. 5b).
Discussion
Similar to other tissue sources such as bone marrow,
MSC populations in dental pulp are recognised to be
heterogeneous populations, with isolated DPSCs demon-
strating differences in proliferative rates and ability to
differentiate along various lineages. The present study
was successful in isolating DPSCs from adult human
dental pulp tissues, in order to characterize the relative
expansion potentials of individual DPSC populations
through to cellular senescence; and the impact of these
proliferative lifespan differences on stem/progenitor cell
characteristics and multi-potent differentiation potential.
Although many animal and human studies have estab-
lished the effects of increasing donor chronological age
on the impairment of stem/progenitor cell regenerative
capabilities [20–24], to our knowledge, this is the first
study to report inherent differences in the telomere
lengths of individual DPSC populations from within a
young donor age group (18–30 years); and their correla-
tions to the distinct differentiation capabilities of each
population. Indeed, despite DPSCs from young adults
with similar donor age ranges having previously been
reported to exhibit no significant differences in prolifera-
tive or differentiation potential [23, 25], this study identi-
fied differences between high (A3) and low (A1 and A2)
proliferative capacity DPSC populations, even from the
same pulpal tissue sample.
Fig. 5 Effects of prolonged in vitro culture expansion on DPSC differentiation capabilities. a Osteogenic differentiation potential of high
proliferative capacity, A3, was greatly reduced following culture expansion from 30 PDs, to 62 PDs and 75 PDs; apparent by a reduction in alizarin
red staining and the loss of osteogenic marker Runx2, osteocalcin (OCN) and osteopontin (OPN) expression (right panel). b Loss of A3 osteogenic
differentiation potential was concomitant with the increased presence of enlarged intracellular lipid vesicles (Oil Red O staining) and the
increased expression of early and late adipogenic markers, PPARγ and lipoprotein lipase (LPL, right panel). No staining was observed in control
cultures in the absence of osteogenic or adipogenic media. Scale bars = 100 μm
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DPSC population, A3, possessed an extensive prolifer-
ative capacity (>80 PDs), which was 2-4× the prolifera-
tive lifespans of other DPSC populations expanded (20–
35 PDs). In support of these findings, A3 was further
shown to be morphologically smaller, possessed fewer
senescence-associated β-galactosidase positive cells and
lacked the expression of p53 and p16INK4a, at PDs where
low proliferative capacity DPSCs (A1, A2, B1, C2 and
C3) demonstrated increased detection of these
senescence-associated markers. Such conclusions are
consistent with only 20% of purified DPSCs being able
to proliferate beyond 20 PDs, whilst it can be surmised
that high proliferative capacity DPSCs, such as A3, are
responsible for the extensive expansion potential of het-
erogeneous DPSC populations (>120 PDs) in vitro [5, 7],
as DPSCs with less proliferative potential are selectively
lost from the mixed population during extended sub-
culture [15, 16]. A consequence of A3 possessing a su-
perior proliferative lifespan was the retention of stem
cell characteristics, evident by the maintenance of
marker expression (CD73, CD90 and CD105) for longer
periods in culture (≥23 PDs), compared to the other
DPSCs analysed. A3 was also the only population cap-
able of multi-potent osteogenic, chondrogenic and adi-
pogenic differentiation, at least up to 30 PDs in culture.
In contrast, other DPSCs appeared lineage-restricted to
osteogenic differentiation only. Therefore, there appears
to be a clear association between DPSC PDs and the
relative differentiation abilities of these populations.
However, as DPSCs derived from adult teeth are gener-
ally regarded to possess lower proliferation rates and
longer population doubling times than those isolated
from human exfoliated deciduous teeth (SHEDs) [26–
29], it is conceivable that SHEDs are still likely to have
equivalent or even greater proliferative potential than
adult DPSCs.
The principle reason identified to be behind these con-
trasting proliferative responses were the average telo-
mere lengths of the DPSC populations. Although it is
possible that these differences reflect the relative number
of cell divisions undertaken by each stem cell before iso-
lation, such contrasting telomere lengths may also sug-
gest the existence of sub-populations of DPSCs within
the stem cell population, with superior telomere dy-
namic characteristics. Indeed, at early PDs, A3 (18.9 kb)
demonstrated telomere lengths 1.5–3.5× longer than low
proliferative DPSCs (~5–13 kb). A3 only exhibited
equivalent telomere lengths to those of the low prolifera-
tive DPSCs at much later PDs towards the end of its
proliferative lifespan (6.4 kb, 55 PDs), corresponding to
the increased presence of senescence-associated
markers. Actively proliferating stem cells are well-known
to possess longer telomeres (10–20 kb), compared to
somatic cells (5–15 kb) [30], whilst previous studies have
reported DPSC telomere lengths between 9.4 and
12.1 kb [31]. Therefore, the contrasting telomere lengths
determined for high and low proliferative capacity
DPSCs are generally in line with those previously identi-
fied in MSCs from other sources.
Based on the correlation comparison between cumula-
tive PDs versus original telomere lengths for all DPSCs
analysed, it appears that this relationship is a little more
complex than expected, particularly between the low
proliferative capacity DPSCs (A1, A2, B1, C2 and C3).
For instance, C3 (12.8 kb) had an initial telomere length
2–3× longer than A1 (5.9 kb) and B1 (5.6 kb), yet exhib-
ited similar proliferative capacities (20–35 PDs). The ex-
trinsic and intrinsic factors which influence the
respective telomere lengths and PD capabilities of indi-
vidual DPSC populations remain to be elucidated, al-
though inherent differences due to inter-patient donor
variation are likely to play a significant role. As this ini-
tial proof-of-concept study has only compared 6 separate
DPSC populations (5 low proliferative and 1 high prolif-
erative) from 3 separate donors, we acknowledge that
the present study is somewhat limited, particularly in
terms of number of highly proliferative DPSCs with lon-
ger telomeres assessed. Consequently, further research is
warranted with much larger numbers of high and low
proliferative DPSCs from different donors, in order to
fully establish the relationship between telomere lengths
and how these impact on the overall PD capabilities and
multi-potent differentiation capabilities of individual
DPSC populations.
Although certain studies have reported hTERT expres-
sion in human DPSCs [31, 32], we and others have shown
that human DPSCs possess no or negligible hTERT expres-
sion [33–35]. Therefore, it appears that hTERT may not be
wholly responsible for maintaining telomere lengths in high
proliferative capacity DPSCs or for the significant variations
in DPSC proliferative capabilities, implying that other in-
trinsic telomere protective mechanisms exist [36, 37].
Nonetheless, the later onset of senescence in A3 was sup-
ported by the delayed expression of senescence-associated
genes, most notably p53 and p16INK4a, at PDs where these
and the other senescence marker gene (p21waf1) assessed,
were highly expressed in low proliferative capacity DPSCs.
MSC replicative senescence is acknowledged to be a multi-
step process driven by p53, which promotes growth arrest
by inducing p21waf1 expression, thereby inhibiting G1-S
phase progression [12]. MSC telomere erosion can also ini-
tiate pRb / p16INK4a checkpoints, triggering permanent sen-
escent states by preventing pRB phosphorylation and
suppressing cell proliferation. Alternatively, senescence me-
diators, such as p53, p16INK4a and pRb, are also associated
with premature/telomere-independent senescence [12].
The proliferative, telomere length reductions and
senescence-related marker detection with increasing
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proliferative lifespan presented herein, firmly suggest that
the senescence of high proliferative capacity DPSCs, such
as A3, is a consequence of replicative senescence; although
it is plausible that both G1-S phase inhibition and pRb/
p16INK4a checkpoint initiation contribute to A3 senescence
[12]. In contrast, as p53 and p16INK4a are also implicated in
the onset of premature senescence, we can only speculate
at present which is the principle mechanism of early senes-
cence and the reasons underlying the pre-existing short-
ened telomeres in low proliferative capacity DPSCs,
following their isolation and short-term in vitro expansion.
Nonetheless, as p53 and p16INK4a have both been demon-
strated to be the principal mediators of senescence in MSCs
[23, 34, 38, 39], as p21waf1 also has a role in maintaining
stem cell renewal due to its positive effects on cell cycle
progression [40]; the contrasting p53 and p16INK4a expres-
sion between high (A3) and low (A1, A2, B1, C2 and C3)
proliferative capacity DPSCs further confirms the earlier
onset of senescence with less proliferative populations at
early PDs, compared to A3.
Although telomere length maintenance is recognized to
facilitate cell division in stem cell populations [41], a not-
able observation within this study was the impact that
contrasting telomere dynamics between high and low pro-
liferative capacity DPSCs has on lineage differentiation
capabilities. Whilst A3 exhibited multi-potency towards
osteogenic, chondrogenic and adipogenic lineages at early
PDs, low proliferative capacity DPSCs, such as A1 and B1,
were only uni-potent for osteogenesis. Only following ex-
tensive culture expansion beyond 30 PDs did the osteo-
genic potential of A3 decline, with a corresponding
increase in adipogenic differentiation. Such findings con-
cur with previous reports of reduced multi-potency in
DPSCs and MSCs from other sources, with extensive pro-
liferative expansion and senescence [23, 34, 42, 43]. Evi-
dence indicates that osteogenesis and adipogenesis are
inversely regulated by transcription factors, Runx2 and
PPARγ, with changes to cellular osteogenic/adipogenic po-
tential with age being a consequence of transcription fac-
tor dysregulation [41, 43].
Another key consideration relating to the findings, is
whether the contrasting regenerative properties between
high and low proliferative capacity DPSC populations re-
flect their isolation from different mesodermal or neuro-
ectodermal origins [44, 45], stem cell niches within the
dental pulp [2], or are from the same origin, but are at
different stages within the proposed hierarchical model
for adult stem cells [8]. Although the nature and origins
of these DPSCs within dental pulpal tissues have yet to
be fully elucidated, the absence of cell surface marker,
CD271 (nerve growth factor receptor p75, LNGFR), ex-
pression in high proliferative capacity and multi-potent
DPSCs, such as A3, may suggest that such populations
are not neural crest- or sub-odontoblast layer-derived, as
CD271+ cells are regarded as being of neural crest origin
and have been located within the cell-rich, sub-
odontoblast region of dental pulp [44, 46]. In line with
the uni-potentiality of low proliferative capacity DPSCs,
CD271 has been proposed to inhibit DPSC adipogenic,
chondrogenic, myogenic and osteogenic potential [47,
48], although not all studies have demonstrated
complete inhibition of multi-potent differentiation in
CD271-expressing DPSCs [44, 45]. Nonetheless, positive
CD271 expression in low proliferative capacity DPSCs
(A1, A2, B1, C2 and C3), may provide further credence
to these cells being more lineage restricted than high
proliferative capacity DPSCs, such as A3.
The prominence of low proliferative capacity and less
potent DPSC populations in the present study may imply
that high proliferative capacity/multi-potent DPSCs with
longer telomere and lacking CD271 expression represent a
minor population within the heterogeneous DPSCs in den-
tal pulp tissues; meaning that highly proliferative/long telo-
mere DPSC populations are more difficult to identify and
isolate from pulpal tissues, although donor variability is
also likely to contribute to this. However, the identification
of telomere length and CD271 expression differences be-
tween high and low proliferative capacity and multi-/uni-
potent DPSCs does advocate their use as potential pheno-
typic biomarkers for the identification and selective isola-
tion of superior proliferative capacity DPSC populations
from dental pulp tissues for regenerative medicine pur-
poses. Variations in telomere lengths have previously been
used as selective markers for the isolation of particular
stem/progenitor cell populations from tissues, such as
bone marrow and cartilage [49, 50]. Furthermore, CD271
has recently been identified to be highly expressed in
STRO-1+/c-Kit+/CD34+ DPSC populations, possessing
slow proliferation rates, reduced stemness and early-onset
senescence; compared to their STRO-1+/c-Kit+/CD34−
counterparts [45]. However, despite differences in CD271
expression, both DPSC sub-populations exhibited similar
osteogenic, myogenic and adipogenic differentiation, al-
though STRO-1+/c-Kit+/CD34+ DPSCs expressing CD271
demonstrated greater neurogenic lineage commitment.
High CD90+ expressing DPSCs with low CD271 expres-
sion have also been demonstrated to possess superior
colony-forming efficiencies, prolonged in vitro prolifera-
tive/multi-lineage potential; and enhanced in vivo bone for-
mation capabilities, versus CD90+ / CD271+ DPSCs [48].
Conclusions
This study has reiterated the significant variability in the
proliferative and differentiation capabilities for individual
DPSC populations expanded from individual human
teeth from donors within a similar age range; and even
identified inherent differences between DPSC popula-
tions derived from the same patient. The findings
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presented also strongly support the use of telomere
length and CD271 expression as viable markers of high
proliferative capacity and multi-potent DPSC popula-
tions. Consequently, if such superior DPSC populations
are to be fully exploited for regenerative medicine, we
must utilise these and other potential markers of DPSC
proliferation and senescence, such as Bmi-1 and SSEA-4
[34, 51]. Such criteria will allow the optimization of
population selection by selectively screening and isolat-
ing better quality DPSCs from whole dental pulp tissues
for in vitro expansion and assessment, aiding the transla-
tional development of more effective DPSC-based ther-
apies for clinical evaluation and application.
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